hormone receptor positive breast cancer

June 12, 2019

Combining 2 Assessments of Breast Cancer Recurrence Risk May Help Guide Use of Adjuvant Chemotherapy

News

Adding an assessment of a woman’s clinical risk to Genomic Health‘s genomic test Oncotype DX to estimate the likelihood of breast cancer recurrence may spare more young women from having ... Read more

October 12, 2016

Advanced Breast Cancer Outcome Improved with Femara, Ribociclib Combination

News

Combining Norvartis‘ CDK4/6 inhibitor ribociclib with Femara (letrozole) may be a promising first-line therapy for hormone receptor (HR)-positive breast cancer patients, according to recent data from a Phase 3 clinical ... Read more

September 18, 2014September 18, 2014

Study Questions Benefit of Endocrine Therapy in Elderly Women with Low Risk Hormone Receptor Positive Breast Cancer

Breast Cancer News, News

Researchers at Fox Chase Cancer Center have showed that combining endocrine therapy and radiation therapy for breast conservation of women with hormone-receptor positive (HR+) invasive breast cancer may not be necessary ... Read more